SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) financial statements, including revenue, expenses, profit, and loss

The total revenue of 0RG8 for the last quarter is 676.30 M EUR, and it's 4.32% lower compared to the previous quarter. The net income of Q1 24 is 56.10 M EUR.